Telomir Pharmaceuticals, Inc. (TELO)
NASDAQ: TELO · Real-Time Price · USD
1.190
-0.070 (-5.56%)
At close: May 18, 2026, 4:00 PM EDT
1.240
+0.050 (4.20%)
After-hours: May 18, 2026, 4:55 PM EDT
Telomir Pharmaceuticals Market Cap
Telomir Pharmaceuticals has a market cap or net worth of $41.26 million as of May 18, 2026. Its market cap has decreased by -44.77% in one year.
Market Cap
41.26M
Enterprise Value
36.24M
1-Year Change
-44.77%
Ranking
Category
Stock Price
$1.19
Market Cap Chart
Since the IPO on February 9, 2024, Telomir Pharmaceuticals's market cap has decreased from $207.27M to $41.26M, a decrease of -80.09%. That is a compound annual growth rate of -51.00%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 15, 2026 | 43.32M | -5.26% |
| Dec 31, 2025 | 45.73M | -62.70% |
| Dec 31, 2024 | 122.58M | -40.86% |
| Feb 9, 2024 | 207.27M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| aTyr Pharma | 49.42M |
| Metagenomi Therapeutics | 49.32M |
| Hyperion DeFi | 47.73M |
| Estrella Immunopharma | 47.36M |
| Nutriband | 43.76M |
| Lite Strategy | 42.54M |
| Atossa Therapeutics | 41.77M |
| INmune Bio | 41.21M |